Long-lived skin models are extending how researchers study the effects of skincare compounds on living human tissue. Outer Bio’s Yuna platform keeps full-thickness human skin viable for four or more weeks while preserving its native architecture and resident immune function. This longer testing window allows researchers to examine biological processes such as collagen remodeling, inflammation and cellular senescence that develop over time. Yuna also generates multi-omic data that Outer Bio uses to train machine-learning models and prioritize compounds for further testing.
The platform could give skincare brands, ingredient suppliers and biopharma companies access to more detailed human-skin data before moving potential compounds into clinical studies. Outer Bio can also build a growing proprietary dataset as additional treatments and donors are studied, strengthening its discovery capabilities. By offering Yuna through select partnerships, the company creates another commercial pathway while accelerating the search for new skincare bioactives.
Image Credit: Outer Bio
Why This Trend Is Growing
- Extended Tissue Testing
- Longer-lived human skin models create room for studying slow biological changes, opening new pathways for preclinical validation beyond short-term irritation or efficacy screens.
- Multi-omic Skincare Discovery
- Rich molecular datasets from viable tissue systems are reshaping ingredient development by linking cosmetic claims to deeper biological mechanisms.
- AI-prioritized Bioactives
- Machine-learning models trained on proprietary human-skin data can compress discovery timelines and reveal overlooked compounds with commercial skincare potential.
Industries Being Reshaped
- Skincare
- Brands gain access to more predictive human-tissue testing that supports differentiated product claims and reduces reliance on less representative early-stage models.
- Biopharmaceuticals
- Human skin platforms provide a translational bridge for dermatology therapeutics, improving compound selection before costly clinical studies begin.
- Contract Research
- Specialized testing partners can build premium service models around long-duration tissue viability, immune-function preservation and integrated data analytics.
